Bumper Offer - Urjas oil Just @ Rs. 1
Segera ER 40 Tablet is a commercial drug that is prescribed in the form of Tablet. It is primarily used for the treatment of Gout. Secondary and off-label uses of Segera ER 40 Tablet have also been mentioned below.
The right dosage of Segera ER 40 Tablet depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
Besides the aforementioned side effects, there are other adverse effects of Segera ER 40 Tablet as well, which are listed below. Such side effects of Segera ER 40 Tablet normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Segera ER 40 Tablet's effect is Severe during pregnancy and Severe for lactating mothers. It is important to know if Segera ER 40 Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Segera ER 40 Tablet related warnings section.
Other contraindications of Segera ER 40 Tablet have been discussed in the sections ahead.
Drug reaction of Segera ER 40 Tablet with other medicines has been reported. See below for a complete list.
In addition to these precautions, you may also note that Segera ER 40 Tablet is safe while driving, and is is addictive in nature.
Segera ER 40 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Segera ER 40 Tablet is used -
Moderate
Mild
Is the use of Segera ER 40 Tablet safe for pregnant women?
Segera shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Segera ER 40 Tablet safe during breastfeeding?
Segera should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Segera ER 40 Tablet on the Kidneys?
There can be some harmful effects on your kidneys after taking Segera. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Segera ER 40 Tablet on the Liver?
Segera has very mild side effects on the liver.
What is the effect of Segera ER 40 Tablet on the Heart?
Segera may cause harmful effects on the heart. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
Segera ER 40 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Segera ER 40 Tablet unless your doctor advises you to do so -
Is this Segera ER 40 Tablet habit forming or addictive?
Segera ER 40 Tablet is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can comfortably use machinery or drive after taking Segera ER 40 Tablet since it will not make you feel sleepy.
Is it safe?
Segera ER 40 Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Segera ER 40 Tablet for mental disorders.
Interaction between Food and Segera ER 40 Tablet
There is no information on the effects of taking Segera ER 40 Tablet with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Segera ER 40 Tablet
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Segera ER 40 Tablet.
No, Segera should not be discontinued without doctors advice. You are recommended to always consult a doctor before discontinuing this medicine.
Yes, Segera is safe to use, if taken in the prescribed amount for a specified time as advised by the doctor. However, few side effects have been observed at the regular doses such as joint pain (arthralgia), nausea, and rash. Do not hesitate to inform your doctor if you are facing any of the above side effects.
Yes, Segera can be taken with prednisolone. No harmful drug interaction has been reported between them. It is safe to take Segera along with prednisolone if taken as directed by the doctor. However, if you feel any discomfort after taking this drug do not hesitate to inform your doctor.
Segera is a brand name of febuxostat and it comes in the form of a tablet. It is an antigout agent that belongs to the class of drugs known as xanthine oxidase inhibitors. It is a prescription drug that is used in the management of gout (arthritis that causes intense pain and redness in the joints due to deposition of uric acid crystals). Apart from the management of gout Segera is sometimes also given for hyperuricemia (an excess of uric acid in the blood) which is caused by chemotherapy drugs.
Yes, Segera might cause constipation in some patients. The exact cause of constipation is unknown. If you are experiencing constipation after taking this drug then try to take laxative such as Isabgol and eat less spicy highly fibrous food.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 217
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 548-549
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 217
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 548-549
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 217
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 548-549
